Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'BIALER M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 66 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bialer, M; Johannessen, SI; Kupferberg, HJ; Levy, RH; Loiseau, P; Perucca, E
      Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)

      EPILEPSY RESEARCH
    2. Wasserman, M; Yagen, B; Blotnik, S; Papo, N; Bialer, M
      Stereoselective pharmacokinetic analysis and antiepileptic activity of N-2-hydroxypropyl valpromide, a central nervous system-active chiral valproylamide

      THERAPEUTIC DRUG MONITORING
    3. Isoherranen, N; Yagen, T; Soback, T; Roeder, M; Schurig, V; Bialer, M
      Pharmacokinetics of levetiracetam and its enantiomer (R)-alpha-ethyl-2-oxo-pyrrolidine acetamide in dogs

      EPILEPSIA
    4. Isoherranen, N; Woodhead, JH; White, HS; Bialer, M
      Anticonvulsant profile of valrocemide (TV1901): A new antiepileptic drug

      EPILEPSIA
    5. Isoherranen, N; Roeder, M; Soback, S; Yagen, B; Schurig, V; Bialer, M
      Enantioselective analysis of levetiracetam and its enantiomer R-alpha-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detection

      JOURNAL OF CHROMATOGRAPHY B
    6. Volosov, A; Bialer, M; Sun, XD; Perucca, E; Sintov, A; Yagen, B
      Simultaneous stereoselective high-performance liquid chromatographic determination of 10-hydroxycarbazepine and its metabolite carbamazepine-10,11-trans-dihydrodiol in human urine

      JOURNAL OF CHROMATOGRAPHY B
    7. Spiegelstein, O; Kroetz, DL; Levy, RH; Yagen, B; Hurst, SI; Levi, M; Haj-Yehia, A; Bialer, M
      Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid

      PHARMACEUTICAL RESEARCH
    8. Lindekens, N; Smolders, I; Khan, GM; Bialer, M; Ebinger, G; Michotte, Y
      In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy

      PHARMACEUTICAL RESEARCH
    9. Britzi, M; Bialer, M; Arcavi, L; Shachbari, A; Kapitulnik, J; Soback, S
      Genetic polymorphism of CYP2D6 and CYP2C19 metabolism determined by phenotyping Israeli ethnic groups

      THERAPEUTIC DRUG MONITORING
    10. Spiegelstein, O; Yagen, B; Bennett, GD; Finnell, RH; Blotnik, S; Bialer, M
      Stereoselective pharmacokinetic analysis of valnoctamide, a CNS-active chiral amide analogue of valproic acid, in dogs, rats, and mice

      THERAPEUTIC DRUG MONITORING
    11. Volosov, A; Yagen, B; Bialer, M
      Comparative stereoselective pharmacokinetic analysis of 10-hydroxycarbazepine after oral administration of its individual enantiomers and the racemicmixture to dogs

      EPILEPSIA
    12. Bialer, M
      From Vermont to Germany - The life of nurse Carolyne Reed, age 101.

      AMERICAN JOURNAL OF NURSING
    13. Roeder, M; Spiegelstein, O; Schurig, V; Bialer, M; Yagen, B
      Absolute configuration of the four stereoisomers of valnoctamide (2-ethyl-3-methylvaleramide), a potentially new stereospecific antiepileptic and CNSdrug

      TETRAHEDRON-ASYMMETRY
    14. Sussan, S; Dagan, A; Blotnik, S; Bialer, M
      The structural requirements for the design of antiepileptic-glycine derivatives

      EPILEPSY RESEARCH
    15. Bialer, M; Johannessen, SI; Kupferberg, HJ; Levy, RH; Loiseau, P; Perucca, E
      Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)

      EPILEPSY RESEARCH
    16. Sussan, S; Dagan, A; Bialer, M
      Pharmacokinetic analysis and anticonvulsant activity of glycine and glycinamide derivatives

      EPILEPSY RESEARCH
    17. Spiegelstein, O; Bialer, M; Radatz, M; Nau, H; Yagen, B
      Enantioselective synthesis and teratogenicity of propylisopropyl acetamide, a CNS-active chiral amide analogue of valproic acid

      CHIRALITY
    18. Spiegelstein, O; Yagen, B; Levy, RH; Finnell, RH; Bennett, GD; Roeder, M; Schurig, V; Bialer, M
      Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acid

      PHARMACEUTICAL RESEARCH
    19. Bialer, M
      Pharmacokinetic considerations in the design of better and safer new antiepileptic drugs

      JOURNAL OF CONTROLLED RELEASE
    20. Volosov, A; Sintov, A; Bialer, M
      Stereoselective pharmacokinetic analysis of the antiepileptic 10-hydroxycarbazepine in dogs

      THERAPEUTIC DRUG MONITORING
    21. Volosov, A; Bialer, M
      Use of mean residence time to determine the magnitude of difference between rate constants and to calculate t(max) in the Bateman equation

      BIOPHARMACEUTICS & DRUG DISPOSITION
    22. Spiegelstein, O; Yagen, B; Bialer, M
      Structure-pharmacokinetic-pharmacodynamic relationships of N-alkyl derivatives of the new antiepileptic drug valproyl glycinamide

      EPILEPSIA
    23. Volosov, A; Sun, XD; Perucca, E; Yagen, B; Sintov, A; Perucca, E; Yagen, B; Sintov, A; Bialer, M
      Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    24. BLOTNIK S; BERGMAN F; BIALER M
      DISPOSITION OF 2 TETRAMETHYLCYCLOPROPANE ANALOGS OF VALPROMIDE IN THEBRAIN, LIVER, PLASMA AND URINE OF RATS

      European journal of pharmaceutical sciences
    25. BIALER M; ARCAVI L; SUSSAN S; VOLOSOV A; YACOBI A; MOROS D; LEVITT B; LAOR A
      EXISTING AND NEW CRITERIA FOR BIOEQUIVALENCE EVALUATION OF NEW CONTROLLED-RELEASE (CR) PRODUCTS OF CARBAMAZEPINE

      Epilepsy research
    26. RADATZ M; EHLERS K; YAGEN B; BIALER M; NAU H
      VALNOCTAMIDE, VALPROMIDE AND VALNOCTIC ACID ARE MUCH LESS TERATOGENICIN MICE THAN VALPROIC ACID

      Epilepsy research
    27. BIALER M; LEVY RH; PERUCCA E
      DOES CARBAMAZEPINE HAVE A NARROW THERAPEUTIC PLASMA-CONCENTRATION RANGE

      Therapeutic drug monitoring
    28. BIALER M; YACOBI A; MOROS D; LEVITT B; HOULE JM; MUNSAKA MS
      CRITERIA TO ASSESS IN-VIVO PERFORMANCE AND BIOEQUIVALENCE OF GENERIC CONTROLLED-RELEASE FORMULATIONS OF CARBAMAZEPINE

      Epilepsia
    29. SPIEGELSTEIN O; BIALER M; YAGEN B
      ISOLATION OF N,N-DIALKYLATED DERIVATIVES OF VALPROYLGLYCINAMIDE FROM DOG PLASMA BY ACTIVE CHARCOAL ADSORPTION AND THEIR QUANTIFICATION BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Journal of chromatography B. Biomedical sciences and applications
    30. PETRIKOVSKY BM; GROSS B; BIALER M; SOLAMANZADEH K; SIMHAEE E
      PRENATAL-DIAGNOSIS OF PSEUDOTHALIDOMIDE SYNDROME IN CONSECUTIVE PREGNANCIES OF A CONSANGUINEOUS COUPLE

      Ultrasound in obstetrics & gynecology
    31. BIALER M; JOHANNESSEN SI; KUPFERBERG HJ; LEVY RH; LOISEAU P; PERUCCA E
      CONFERENCE REPORT - PROGRESS REPORT ON NEW ANTIEPILEPTIC DRUGS - A SUMMARY OF THE 3RD EILAT-CONFERENCE (VOL 25, PG 299, 1996)

      Epilepsy research
    32. BLOTNIK S; BERGMAN F; BIALER M
      THE DISPOSITION OF VALPROYL GLYCINAMIDE AND VALPROYL GLYCINE IN RATS

      Pharmaceutical research
    33. LEVI M; YAGEN B; BIALER M
      PHARMACOKINETICS AND ANTIEPILEPTIC ACTIVITY OF VALPROYL HYDROXAMIC ACID-DERIVATIVES

      Pharmaceutical research
    34. SHALON L; MARKOWITZ J; BIALER M; KAHN E; WEINBLATT M; GIARDIELLO FM; LUCE MC; DAUM F
      OVARIAN NEOPLASM AND ENDOMETRIOID CARCINOMA IN A PATIENT WITH TURCOT-SYNDROME

      Journal of pediatric gastroenterology and nutrition
    35. HADAD S; BIALER M
      PHARMACOKINETIC ANALYSIS AND ANTIEPILEPTIC ACTIVITY OF 2 NEW ISOMERS OF N-VALPROYL GLYCINAMIDE

      Biopharmaceutics & drug disposition
    36. LUCE M; KAHN E; BIALER M; SHALON L; MARKOWITZ J
      A HOMOZYGOUS HPMS2 MUTATION IN 2 PATIENTS WITH TURCOT-SYNDROME (TS)

      Laboratory investigation
    37. BAREL S; YAGEN B; SCHURIG V; SOBACK S; PISANI F; PERUCCA E; BIALER M
      STEREOSELECTIVE PHARMACOKINETIC ANALYSIS OF VALNOCTAMIDE IN HEALTHY-SUBJECTS AND IN PATIENTS WITH EPILEPSY

      Clinical pharmacology and therapeutics
    38. PETRIKOVSKY B; GROSS B; SPINAZZOLA R; BIALER M
      SINGLE-NEEDLE INSERTION TECHNIQUE FOR THORACENTESIS FOR BILATERAL PLEURAL EFFUSIONS

      Fetal diagnosis and therapy
    39. BIALER M; JOHANNESSEN SI; KUPFERBERG HJ; LEVY RH; LOISEAU P; PERUCCA E
      PROGRESS REPORT ON NEW ANTIEPILEPTIC DRUGS - A SUMMARY OF THE 3RD EILAT CONFERENCE

      Epilepsy research
    40. BIALER M; HADAD S; KADRY B; ABDULHAI A; HAJYEHIA A; STERLING J; HERZIG Y; YAGEN B
      PHARMACOKINETIC ANALYSIS AND ANTIEPILEPTIC ACTIVITY OF TETRAMETHYLCYCLOPROPANE ANALOGS OF VALPROMIDE

      Pharmaceutical research
    41. PERUCCA E; BIALER M
      THE CLINICAL PHARMACOKINETICS OF THE NEWER ANTIEPILEPTIC DRUGS - FOCUS ON TOPIRAMATE, ZONISAMIDE AND TIAGABINE

      Clinical pharmacokinetics
    42. GILBERT F; LI Z; ARZIMANOGLOU I; BIALER M; DENNING C; GORVOY J; HONOROF J; ORES C; QUITTELL L; ROSSOFF L; VALVERDE K
      CLINICAL SPECTRUM IN HOMOZYGOTES AND COMPOUND HETEROZYGOTES INHERITING CYSTIC-FIBROSIS MUTATION 3849-GREATER-THAN-T - SIGNIFICANCE FOR GENETICISTS (VOL 58, PG 356, 1995)(10KBC)

      American journal of medical genetics
    43. BIALER M; KADRY B; ABDULHAI A; HAJYEHIA A; STERLING J; HERZIG Y; SHIRVAN M
      PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF (E)-2-ENE VALPROYL DERIVATIVES OF GLYCINE AND VALPROYL DERIVATIVES OF NIPECOTIC ACID

      Biopharmaceutics & drug disposition
    44. BLOTNIK S; BERGMAN F; BIALER M
      DISPOSITION OF VALPROMIDE, VALPROIC ACID, AND VALNOCTAMIDE IN THE BRAIN, LIVER, PLASMA, AND URINE OF RATS

      Drug metabolism and disposition
    45. STABLES JP; BIALER M; JOHANNESSEN SI; KUPFERBERG HJ; LEVY RH; LOISEAU P; PERUCCA E
      PROGRESS REPORT ON NEW ANTIEPILEPTIC DRUGS A SUMMARY OF THE 2ND EILAT-CONFERENCE

      Epilepsy research
    46. HADAD S; BIALER M
      PHARMACOKINETIC ANALYSIS AND ANTIEPILEPTIC ACTIVITY OF N-VALPROYL DERIVATIVES OF GABA AND GLYCINE

      Pharmaceutical research
    47. TAFF IP; ZITO J; BIALER M; MONTERA L
      MAGNETIC-RESONANCE-IMAGING OF THE CENTRAL-NERVOUS-SYSTEM IN PEDIATRICNEUROFIBROMATOSIS TYPE-1

      Annals of neurology
    48. GILBERT F; LI Z; ARZIMANOGLOU I; BIALER M; DENNING C; GORVOY J; HONOROF J; ORES C; QUITTELL L; ROSSOFF L; VALVERDE K
      CLINICAL SPECTRUM IN HOMOZYGOTES AND COMPOUND HETEROZYGOTES INHERITING CYSTIC-FIBROSIS MUTATION 3849-GREATER-THAN-T - SIGNIFICANCE FOR GENETICISTS(10KBC)

      American journal of medical genetics
    49. SAMARA E; AVNIR D; LADKANI D; BIALER M
      PHARMACOKINETIC ANALYSIS OF DIETHYLCARBONATE PRODRUGS OF IBUPROFEN AND NAPROXEN

      Biopharmaceutics & drug disposition
    50. BIALER M; SUSSAN S; SALACH OA; DANENBERG HD; BENDAVID J; GIBOR Y; LAOR A
      CRITERIA TO ASSESS IN-VIVO PERFORMANCE OF SUSTAINED-RELEASE PRODUCTS - APPLICATION TO DILTIAZEM FORMULATIONS

      Journal of pharmaceutical sciences
    51. HADAD S; BIALER M
      PHARMACOKINETIC ANALYSIS AND ANTIEPILEPTIC ACTIVITY OF NOVEL VALPROATE DERIVATIVES OF GABA AND GLYCINE

      Epilepsia
    52. ABUSALACH O; HADAD S; HAJYEHIA A; SUSSAN S; BIALER M
      COMPARATIVE PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF PHTHLALOYL GLYCINE DERIVATIVES WITH POTENTIAL ANTIEPILEPTIC ACTIVITY

      Epilepsia
    53. BIALER M; HAJYEHIA A; BADIR K; HADAD S
      CAN WE DEVELOP IMPROVED DERIVATIVES OF VALPROIC ACID

      Pharmacy world & science
    54. BIALER M; PHARAJ Z; ZUCKERMAN S; RAZ I; ABRAMSKY O; STERLING J; LADKANI D
      PHARMACOKINETIC ANALYSIS OF VALDICE - A DIETHYLCARBONATE PRODRUG OF VALPROIC ACID

      European journal of pharmaceutical sciences
    55. ABUSALACH O; HADAD S; HAJYEHIA A; SUSSAN S; BIALER M
      COMPARATIVE PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF PHTHALOYLGLYCINE DERIVATIVES WITH POTENTIAL ANTIEPILEPTIC ACTIVITY

      Pharmaceutical research
    56. WEINBLATT M; PETRIKOVSKY B; BIALER M; KOCHEN J; HARPER R
      PRENATAL EVALUATION AND IN-UTERO PLATELET TRANSFUSION FOR THROMBOCYTOPENIA ABSENT RADII SYNDROME

      Prenatal diagnosis
    57. BAREL S; YAGEN B; BIALER M
      PHARMACOKINETIC PROFILE OF CONJUGATED VERRUCAROL URINARY METABOLITES IN DOGS

      Biopharmaceutics & drug disposition
    58. BIALER M; HADAD S; GOLOMB G; BAREL S; SAMARA E; ABUSALACH O; BERKMAN N; DANENBERG HD; BENDAVID J; CARON D; KAPLAN R; TAMIR A; FRIEDMAN M
      PHARMACOKINETIC ANALYSIS OF 2 NEW SUSTAINED-RELEASE PRODUCTS OF DILTIAZEM DESIGNED FOR TWICE-DAILY AND ONCE-DAILY TREATMENT

      Biopharmaceutics & drug disposition
    59. SOBACK S; GIPS M; BIALER M; BOR A
      EFFECT OF LACTATION ON SINGLE-DOSE PHARMACOKINETICS OF NORFLOXACIN NICOTINATE IN EWES

      Antimicrobial agents and chemotherapy
    60. PERUCCA E; GATTI G; CIPOLLA G; SPINA E; BAREL S; SOBACK S; GIPS M; BIALER M
      INHIBITION OF DIAZEPAM METABOLISM BY FLUVOXAMINE - A PHARMACOKINETIC STUDY IN NORMAL VOLUNTEERS

      Clinical pharmacology and therapeutics
    61. GABIZON AA; BARENHOLZ Y; BIALER M
      PROLONGATION OF THE CIRCULATION TIME OF DOXORUBICIN ENCAPSULATED IN LIPOSOMES CONTAINING A POLYETHYLENE GLYCOL-DERIVATIZED PHOSPHOLIPID - PHARMACOKINETIC STUDIES IN RODENTS AND DOGS

      Pharmaceutical research
    62. YAGEN B; BIALER M
      METABOLISM AND PHARMACOKINETICS OF T-2 TOXIN AND RELATED TRICHOTHECENES

      Drug metabolism reviews
    63. BIALER M
      COMPARATIVE PHARMACOKINETICS OF THE NEWER ANTIEPILEPTIC DRUGS

      Clinical pharmacokinetics
    64. PISANI F; HAJYEHIA A; FAZIO A; ARTESI C; OTERI G; PERUCCA E; KROETZ DL; LEVY RH; BIALER M
      CARBAMAZEPINE VALNOCTAMIDE INTERACTION IN EPILEPTIC PATIENTS - IN-VITRO IN-VIVO CORRELATION

      Epilepsia
    65. BALE A; BIALER M; GAILANI M; DOKRAS A
      PRENATAL, PRESYMPTOMATIC, AND PREIMPLANTATION DIAGNOSIS OF GORLIN SYNDROME

      American journal of human genetics
    66. SAMARA E; BIALER M; HARVEY DJ
      METABOLISM OF CANNABIDIOL BY THE RAT

      European journal of drug metabolism and pharmacokinetics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 05:54:05